Pearl Temple, | |
1251 Muldoon Rd Ste 116, Anchorage, AK 99504-2098 | |
(907) 274-8281 | |
Not Available |
Full Name | Pearl Temple |
---|---|
Gender | Female |
Speciality | Counselor - Mental Health |
Location | 1251 Muldoon Rd Ste 116, Anchorage, Alaska |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1063171312 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Pearl Temple, 1251 Muldoon Rd Ste 116, Anchorage, AK 99504-2098 Ph: (907) 274-8281 | Pearl Temple, 1251 Muldoon Rd Ste 116, Anchorage, AK 99504-2098 Ph: (907) 274-8281 |
News Archive
A groundbreaking study of nearly 4,000 trauma patients evacuated from the frontlines in Afghanistan over a six-year period offers insight that can inform decisions on team composition, staff training and skill mix on the battlefield and beyond.
Juvaris BioTherapeutics, Inc., a biotechnology company developing adjuvanted vaccines for infectious diseases, announced that it has completed the first close on its Series B equity financing of up to $25 million led by SV Life Sciences (SVLS) along with existing investor, Kleiner Perkins Caufield & Byers (KPCB).
Mums-to-be are being advised not to use personal monitors (Doppler devices) to listen to their baby's heartbeat at home over fears that they may lead to delays in seeking help for reduced fetal movements.
Emergent BioSolutions Inc. today announced that it has been awarded five separate grants under the Qualifying Therapeutic Discovery Project (QTDP) Program to support continued development of its therapeutic programs in oncology and autoimmunity. The grants, with a total value of over $1.2 million, will fund Emergent's TRU-016 Small Modular ImmunoPharmaceutical (SMIP™), DRACO anti-CD3 SMIP, X1 TNF-based SCORPION™, X2 CTLA4-based SCORPION, and T-Scorps-based SCORPION therapeutic programs.
Phase Forward, a leading provider of data management solutions for clinical trials and drug safety, today announced a multi-year contract with renowned eye health company Bausch & Lomb. The agreement calls for Bausch & Lomb to implement Phase Forward's InForm™ Global Trial Management (GTM) electronic data capture (EDC) solution, including the Central Coding™ module, in all of its trials, including Surgical, Vision Care and Pharmaceuticals products.
› Verified 5 days ago
Mr. Duncan R Brooks, MS, LPC. Counselor Medicare: Not Enrolled in Medicare Practice Location: 1205 E International Airport Rd Ste 100, Anchorage, AK 99518 Phone: 907-570-6382 Fax: 888-972-3679 | |
Carolyn Michaud, OTD OTR/L Counselor Medicare: Not Enrolled in Medicare Practice Location: 4325 Laurel St Ste 102, Anchorage, AK 99508 Phone: 907-569-5660 | |
Patricia Quinn, Counselor Medicare: Not Enrolled in Medicare Practice Location: 741 Sesame St Ste 1b, Anchorage, AK 99503 Phone: 907-406-2642 | |
Mrs. Rebecca Ann Shestakov, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 6952 Cutty Sark St, Anchorage, AK 99502 Phone: 907-982-5562 | |
Parinita Shetty, Counselor Medicare: Not Enrolled in Medicare Practice Location: 7440 Creekside Center Dr, Anchorage, AK 99504 Phone: 907-279-9640 | |
Tau Vaaia, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1709 Bragaw St, Anchorage, AK 99508 Phone: 907-562-5340 | |
Katie Ogin, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2600 Cordova St, Anchorage, AK 99503 Phone: 907-279-9640 |